Before starting or continuing both medications together, ensure you discuss: Your Complete Medical History: Previous or current mental health conditions, including depression, anxiety, bipolar disorder, or suicidal ideation History of seizures or conditions that lower seizure threshold Eating disorders (past or present) Cardiovascular disease, including hypertension Kidney or liver impairment Thyroid disorders Diabetes and current glycaemic control Gastrointestinal conditions, including pancreatitis or gallbladder disease Eligibility for Wegovy under NICE guidelines (typically requiring specialist weight management services, specific BMI thresholds, and other criteria) All Current Medications: Provide a complete list including: Prescription medications (especially anticoagulants like warfarin, antidiabetic drugs, or medications affecting seizure threshold such as tramadol, antipsychotics, tricyclic antidepressants, or quinolone antibiotics) Medications that affect CYP2B6 enzymes which metabolise bupropion Over-the-counter medicines Herbal supplements and vitamins Recreational substances or alcohol use Treatment Goals and Monitoring: Discuss realistic expectations for weight management and smoking cessation
Approved by the FDA in 2019, Rybelsus mimics naturally occurring glucagon-like peptide-1 hormones to improve blood sugar control through multiple mechanisms, including stimulating glucose-dependent insulin secretion and suppressing excessive glucagon release
M., Van Der Ploeg, L
- GLP-1 RAs are very potential for stroke and more studies are needed to elucidate the mechanisms underlying neuroprotection
Sleep apnea symptoms improve or resolve
DKA (diabetic ketoacidosis) is rare with Ozempic, but it is a life-threatening condition that requires urgent medical attention
